90490 ⎘
Indexing scheme relating to specific properties of organic compounds Isotopically modified compounds, e.g. labelled
Estrogen receptor imaging agents
#24024-hydroxybutyric acid analogs
#24036-chloro-3-(phenyl-d5)-inden-1-one and use thereof
#2404Piperidine inhibitors of Janus kinase 3
#2405Substituted xanthine derivatives
#2406Inhibitors of lysine specific demethylase-1
#2407Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
#2408Deuterated compounds and uses thereof
#2409FLUORO-DERIVATIVES OF PYRAZOLE-SUBSTITUTED AMINO-HETEROARYL COMPOUNDS
#2410DEUTERATED ALK INHIBITORS
#2411CARBAMOYLPYRIDONE DERIVATIVES
#2412Deuterated Ponatinib
#2413Hepatitis C virus inhibitors
#2414Catalytic radiofluorination
#2415Purification method
#2416Compound and organic light-emitting device including the same
#2417Compounds for electronic devices
#2418Nickel fluorinating complexes and uses thereof
#2419Iodine(III)-mediated radiofluorination
#2420Phosphonate compounds for treatment of complement mediated disorders
#2421Ether compounds for treatment of complement mediated disorders
#2422Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#2423Deuterated derivatives of ruxolitinib
#2424Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#2425Amino compounds for treatment of complement mediated disorders
#2426Amide compounds for treatment of complement mediated disorders
#2427Alkyne compounds for treatment of complement mediated disorders
#2428Compounds for treatment of complement mediated disorders
#2429Factor D inhibitors useful for treating inflammatory disorders
#2430Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of Alzheimer's disease
#2431CARBAMATE COMPOUNDS AND METHODS OF USE IN DISEASES OF THE NERVOUS SYSTEM
#2432Stable isotope-labeled aliphatic amino acid and NMR structural analysis of protein using same
#2433Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
#2434Deuterated ibrutinib
#2435Preparation of hydroxy-benzylbenzene derivatives
#2436DEUTERATED 4-HYDROXYBUTYRIC ACID ANALOGS
#2437Heterocyclic derivatives and their use in the treatment of neurological disorders
#2438Digital microfluidic platform for radiochemistry
#2439DEUTERATED DERIVATIVES OF RUXOLITINIB
#2440Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#2441Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
#2442Processes for the preparation of isoindole compounds and isotopologues thereof
#2443PRODUCTION OF 18F-LABELLED COMPOUNDS COMPRISING HYDROLYTIC DEPROTECTION STEP AND SOLID PHASE EXTRACTION
#2444Deuterated vercirnon
#2445Method and catalyst for synthesising aziridine
#2446Deuterated idebenone
#2447Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#2448Compounds useful as inhibitors of ATR kinase
#2449Permeable glycosidase inhibitors and uses thereof
#2450Method for preparing methylated amines
#2451Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#2452Preparation of Technetium-99M Tricarbonyl Labeled Glycine Monomer or Oligomer Containing Probes That Have Biomolecules and Its Application as Imaging Complex-Composition
#2453Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
#2454Phenyl glyoxal probes
#2455Positron emission tomography probe to monitor selected sugar metabolism in vivo
#2456Device and method for the production of radiochemical compounds
#2457Catalytic radiofluorination
#2458Halogenated compounds for cancer imaging and treatment and methods for their use
#2459Substituted xanthine derivatives
#2460Synthesis of deuterated morpholine derivatives
#2461Deuterated rigosertib
#2462Pharmaceutical compounds
#2463DIAGNOSTIC AGENT AND DIAGNOSTIC METHOD FOR IRRITABLE BOWEL SYNDROME INDUCED BY ABNORMAL PROLIFERATION OF ENTEROBACTERIA
#2464Method for preparing fluorine-18 eluent with adjusted PH, and method for labelling fluorine-18 using same
#2465Method for producing hydrogen or heavy hydrogens, method for producing hydrogenated (protiated, deuterated or tritiated) organic compound, method for hydrogenating (protiating, deuterating or tritiating) organic compound, method for dehalogenating organic compound having halogen, and ball for use in mechanochemical reaction
#2466Aspartylamide inhibitors of excitatory amino acid transporters
#2467Deuterated compounds for electronic applications
#2468Radiolabeled amino acids for diagnostic imaging
#2469Inhibitors of cholesterol ester transfer protein
#2470Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#2471Compound and organic light-emitting device including the same
#2472Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
#2473PSMA-binding agents and uses thereof
#2474Pharmaceutical compositions comprising POH derivatives
#2475Pharmaceutical compositions comprising POH derivatives
#2476Process for producing hydrogen or heavy hydrogens, and hydrogenation (protiation, deuteration or tritiation) of organic compounds using same
#24774,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof
#24784-hydroxybutyric acid analogs
#24791,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof
#2480Substituted pentylenetetrazoles as GABA receptor activity modulators
#2481Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#2482Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#2483DEUTERIUM-ENRICHED PRASUGREL
#2484Compositions, methods, and systems for the synthesis and use of imaging agents
#2485Method of making alcohols
#2486[F-18]-labeled L-glutamic acid, [F-18]-labeled L-glutamine, derivatives thereof and use thereof and processes for their preparation
#2487Organic electroluminescence element
#2488Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#2489SUBSTITUTED XANTHINE DERIVATIVES
#2490Organic electroluminescent element, material for organic electroluminescent element and light emitting device, display device, and illumination device, each employing organic electroluminescent element
#2491Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
#2492Method for the synthesis of 18F-labelled molecules
#2493Precursors of glutamate derivatives
#2494Method for the synthesis of F-labelled biomolecules
#2495SIMPLIFIED RADIOSYNTHESIS OF [18F]FLUOROMETHYL BROMIDE
#2496Compounds for treating ophthalmic diseases and disorders
#2497Precursor compound of radioactive halogen-labeled organic compound
#2498Method for diagnosing infection
#2499Tritiated planar carbon forms
#2500Biomass-derived methyl methacrylate and corresponding manufacturing method, uses and polymers
#2501Multicyclic aromatic compound and organic light emitting device using the same
#25024-hydroxybutyric acid analogs
#2503Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
#2504Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
#2505Heterocyclic derivatives and their use in the treatment of neurological disorders
#2506Reactions of aromatic substrates with base-activated hydrosilanes-silylations and reductive cleavage
#2507Quantitative standard for mass spectrometry of proteins
#2508Ligands for imaging cardiac innervation
#2509Process for production of heterodimers of glutamic acid
#2510N-substituted benzamides and methods of use thereof
#2511N-substituted benzamides and methods of use thereof
#2512Anthracene compound and organic electroluminescence element using same
#2513Process simplification for precursor compound
#2514Cognition enhancing compounds and compositions, methods of making, and methods of treating
#2515Compound for organic light-emitting diode and organic light-emitting diode including the same
#2516Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#2517Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
#2518Organic electroluminescent element, compounds and materials used for the organic electroluminescent element, and light-emitting, display and illuminating devices using the elements
#2519Pharmaceutical compositions comprising POH derivatives
#2520Deuterated compounds for electronic applications
#2521Phosphate esters of gyrase and topoisomerase inhibitors
#2522Process for producing hydrogen or heavy hydrogens, and hydrogenation (protiation, deuteration or tritiation) of organic compounds using same
#2523Device and method for the preparation of radiochemical compounds
#2524Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound
#2525Catalytic radiofluorination
#2526Methods for the synthesis of deuterated acrylate salts
#2527Homoglutamic acid derivatives
#2528Method and synthesis
#2529METHOD FOR PRODUCING PRECURSORS FOR L-3,4-DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE A-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-3,4DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE A-METHYLATED DERIVATIVES FROM THE PRECURSOR
#2530Deuterated benzene sulfonamide thiazole compounds
#2531Piperidine inhibitors of janus kinase 3
#2532Deuterium-enriched pyrimidine compounds and derivatives
#2533Heterocyclic compounds and uses thereof
#2534IODINE-LABELED HOMOGLUTAMIC ACID AND GLUTAMIC ACID DERIVATIVES
#2535Isotopically labeled chemically stable reagents and process for the synthesis thereof
#2536Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
#2537Preparation methods of methyl-D3-amine and salts thereof
#2538Purification method
#25394-hydroxybutyric acid analogs
#2540Fused heterocyclic compounds as ion channel modulators
#254111C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent
#2542COMPOUNDS AND THERAPEUTIC USES THEREOF
#2543Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
#2544DEUTERATED COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISEASES
#2545Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
#2546Fluorination of organic compounds
#2547Cyclopropyl modulators of P2Y12 receptor
#2548Method for production of radiation diagnostic imaging agent
#2549Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
#2550Compound having triphenylamine structure, and organic electroluminescent device
#2551Method for rapid fluoromethylation and method for preparation of PET tracer using the same
#2552Single diastereomers of 4-fluoroglutamine and methods of their preparation and use
#2553NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
#2554Deuterated 5,6-dihydro-1-pyridin-2-one compounds
#2555Desmosterol-producing yeast strains and uses thereof
#2556IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA
#2557PROSTACYCLIN DERIVATIVES
#2558Digital microfluidic platform for radiochemistry
#2559Substituted isoindoline-1,3-dione derivatives
#25602,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
#2561Inhibitors of sphingosine kinase
#2562METHOD FOR MULTIPLE QUANTIFICATION OF AMINO GROUP-CONTAINING NON-PEPTIDIC COMPOUND WITH HIGH EFFICIENCY AND HIGH SENSITIVITY AND KIT THEREFOR
#2563Modulators of pharmacokinetic properties of therapeutics
#2564Iodine radiolabelling method
#2565LABELING COMPOUND FOR PET
#2566UNSATURATED CHOLINE ANALOGS AND CHEMICAL SYNTHESIS THEREOF
#2567PREPARATION OF 11C METHYL IODIDE
#2568BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#2569Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran
#2570Method and device for synthesizing radioactive methyl iodide tracer
#2571Catalytic radiofluorination
#2572Radiolabelling Method Using Cycloalkyl Groups
#2573ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION
#2574Heterocyclic derivatives and their use in the treatment of neurological disorders
#2575Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
#2576ANGIOGENIC RESORCINOL DERIVATIVES
#2577COMPOUNDS AND METHODS FOR DETECTION AND QUANTIFICATION OF CARBOXYLIC ACIDS
#2578Trihydroxy polyunsaturated eicosanoid derivatives
#2579DEUTERATED FINGOLIMOD
#2580Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same
#2581No-carrier-added nucleophilic [F-18] fluorination of aromatic compounds
#25824-hydroxybutyric acid analogs
#2583VMP-like sequences of pathogenic
#2584Modular radiochemistry synthesis system
#2585NOVEL PRECURSOR MOLECULES FOR F-18 LABELLED PET TRACERS
#2586F-labeled azide compound, reagent for F-labeling and method for F-labeling of alkyne compound using same
#2587DEUTERIUM ENRICHED RASAGILINE
#2588THIOFLAVIN DERIVATES FOR USE IN THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION
#2589FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#2590Mitochondrial inhibitors to treat human disease
#2591Radiolabeled Fluorine Derivatives of Methionine
#2592Process for preparing acrylic acid from methanol and acetic acid
#2593Process for preparing acrylic acid from ethanol and formaldehyde
#2594DEUTERATED 2-PROPYLPENTANOIC ACID COMPOUNDS
#2595Tetrahydro-pyrido-pyrimidine derivatives
#2596Isotopologues of thalidomide
#2597Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents
#2598Deuterium Modified Benzimidazoles
#2599DIACYLETHYLENEDIAMINE COMPOUND
#2600Deuterium-enriched pyrimidine compounds and derivatives
#2601METHODS TO RADIOLABEL NATURAL ORGANIC MATTER BY REDUCTION WITH HYDROGEN LABELED REDUCING AGENTS
#2602Compositions and methods for inhibition of the JAK pathway
#2603Indole derivatives
#2604Fluorination of aromatic ring systems
#2605Isotopically labeled chemically stable reagents and process for the synthesis thereof
#2606Process for synthesis of tritiated and deuterated thiorphan and acetorphan
#2607BIOMASS-DERIVED METHYL METHACRYLATE AND CORRESPONDING MANUFACTURING METHOD, USES AND POLYMERS
#2608Fluorination of aromatic ring systems
#2609SIDE CHAIN DEUTERATED AMINO ACIDS AND METHODS OF USE
#2610PRODRUGS OF ION CHANNEL MODULATING COMPOUNDS AND USES THEREOF
#2611BENZAZEPINE INHIBITORS OF GAMMA-SECRETASE
#2612Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
#2613Tritiated planar carbon forms
#2614Substituted dioxopiperidinyl phthalimide derivatives
#26153-SUBSTITUTED-6-ARYL PYRIDINES
#2616Isotopically labeled compositions and method
#2617Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#2618Derivatives of dimethylcurcumin
#2619Trihydroxy polyunsaturated eicosanoid derivatives
#26204,6-disubstituted pyrimidines useful as kinase inhibitors
#2621Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
#2622METHOD FOR DETERMINATION OF DELTA-D VALUES OF NON- EXCHANGEABLE HYDROGEN STABLE ISOTOPES ON ETHANOL' S METHYL GROUP BY MEANS OF IRMS INSTRUMENTAL TECHNIQUE
#2623Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
#26242-OXO-1-PYRROLIDINE DERIVATIVES
#2625USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS
#26264,6-diaminopyrimidine stimulators of soluble guanylate cyclase
#2627FLUORIDATION METHOD
#2628DEUTERATED MACROCYCLIC INHIBITORS OF VIRAL NS3 PROTEASE
#2629Automatic Process for Synthesizing F-18-FDDNP
#2630DEUTERIUM-ENRICHED COLCHICINE, THIOCOLCHICINE, AND DERIVATIVES THEREOF; METHODS OF PREPARATION; AND USE THEREOF
#2631Derivative compounds of N-6-Trimethy-L-Lysine for therapeutic use
#2632Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compounds
#2633Method of treating a human being for a class of metabolic defects and energy production disorders
#2634Method of treating a human being for a class of neurological defects and seizure disorders
#2635Targeted delivery of imaging probes for in vivo cellular imaging
#2636Fluoridation of iodonium salts
#2637Niacin prodrugs and deuterated versions thereof
#2638PSMA-binding agents and uses thereof
#2639COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS
#2640Cyclohexane derivatives and uses thereof
#2641Deuterium-enriched bupropion
#2642IN VIVO IMAGING AGENTS
#2643DEUTERIUM-ENRICHED DISUFENTON
#2644PREPARATION AND UTILITY OF CCR5 INHIBITORS
#2645DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS
#2646DEUTERIUM-ENRICHED SALMETEROL
#2647Vandetanib derivatives
#2648Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (PET) imaging for the brain serotonin transporters
#2649Fused polycyclic aromatic compound and organic light emitting device using the compound
#2650Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
#2651Therapies for cancer using isotopically substituted lysine
#2652PROCESS FOR PREPARING ISOTOPICALLY LABELED VITAMINS SUITABLE FOR USE AS ANALYTICAL REFERENCE STANDARDS
#2653Aβ-binding small molecules
#2654Deuterated hepatitis C protease inhibitors
#2655Active enantiomer
#2656New L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
#2657DEUTERATED ALKYL PHOSPHOLIPID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
#2658Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
#2659Sulfonation of polyhydroxyaromatics
#2660Method for preparing precursor of radioactive 3-iodobenzylguanidine
#2661Deuterated compounds for electronic applications
#2662Preparation and use of alkylating agents
#2663DEUTERIUM-ENRICHED BAZEDOXIFENE
#2664Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
#2665Process for production of heterodimers of glutamic acid
#2666Opsin-binding ligands, compositions and methods of use
#2667Method for radio-labeling serotonin transporter ligand, 123I-IADM
#2668METHOD FOR PRODUCING COMPOUND HAVING DEUTERATED AROMATIC RING OR HETEROCYCLIC RING
#2669Modulators of ATP-binding cassette transporters
#2670Substituted isoindoline-1,3-dione derivatives
#2671SYNTHESIS OF ISOTOPICALLY-LABELED FUNCTIONALIZED DIENES
#2672VMP-like sequences of pathogenic
#2673CYCLOBUTANEMETHANAMINE INHIBITORS OF MONOAMINE REUPTAKE
#2674Mass tags for quantitative analyses
#2675Substituted aminopropionic derivatives as neprilysin inhibitors
#2676Processes and intermediates for preparing steric compounds
#2677Piperidine inhibitors of Janus kinase 3
#2678Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
#2679PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B
#2680PREPARATION OF RADIOLABELLED HALOAROMATICS VIA POLYMER-BOUND INTERMEDIATES
#2681Identification of bacterial autoinducer and use in treating bacterial pathogenicity
#2682PEGYLATED ION CHANNEL MODULATING COMPOUNDS
#2683PET PROBE HAVING AN ALKOXY GROUP SUBSTITUTED BY FLUORINE AND HYDROXY GROUP
#2684Labeled molecular imaging agents, methods of making and methods of use
#2685Process for production of radioactive-fluorine-labeled organic compound
#2686METHOD FOR PRODUCING PRECURSORS FOR L-3,4-DIHYDROXY-6- [18F] FLUOROPHENYL ALAINE AND 2- [18F] FLUORO-L-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-3, 4DIHYDROXY-6- [18F] FLUOROPHENYLALANINE AND 2- [18F] FLUORO-L-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES FROM THE PRECURSOR
#2687PROSTACYCLIN DERIVATIVES
#2688Electroactive materials
#2689Method of rapid methylation, kit for preparing PET tracer and method of producing PET tracer
#2690CHEMICAL SYNTHESIS OF I-124BETA CIT IODINE-124 [2-BETA-CARBOMETHOXY-3BETA- (4. -IODOPHENYL) -TROPANE] FOR PET INVESTIGATIONS AND FOR RADIOTHERAPY
#2691COMPOUND, DIAGNOSTIC AGENT, NUCLEAR MAGNETIC RESONANCE ANALYSIS METHOD, NUCLEAR MAGNETIC RESONANCE IMAGING METHOD, MASS SPECTROMETRY METHOD AND MASS SPECTROMETRY IMAGING METHOD
#2692SUBSTITUTED PDE5 INHIBITORS
#2693SUBSTITUTED PHENETHYLAMINES
#2694Ligands for imaging cardiac innervation
#2695[F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED L-GLUTAMINE, DERIVATIVES THEREOF AND USE THEREOF AND PROCESSES FOR THEIR PREPARATION
#2696Catalytic radiofluorination
#2697Radio-methyl vorozole and methods for making and using the same
#2698COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN
#2699Modulators of pharmacokinetic properties of therapeutics
#2700PROSTACYCLIN DERIVATIVES